Barclays’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-656,600
Closed -$29.2M 5199
2021
Q4
$29.2M Buy
656,600
+612,600
+1,392% +$28.3M 0.01% 782
2021
Q3
$2.12M Buy
+44,000
New +$2.44M ﹤0.01% 2305
2019
Q3
Sell
-55,500
Closed -$4.18M 6847
2019
Q2
$4.18M Buy
55,500
+43,000
+344% +$3.09M ﹤0.01% 2037
2019
Q1
$980K Buy
+12,500
New +$835K ﹤0.01% 3417
2018
Q4
Sell
-65,000
Closed -$4.22M 7071
2018
Q3
$4.22M Buy
65,000
+38,800
+148% +$1.9M ﹤0.01% 1992
2018
Q2
$1.06M Buy
+26,200
New +$932K ﹤0.01% 3210
2017
Q3
Sell
-50,000
Closed -$2.07M 6913
2017
Q2
$2.07M Hold
50,000
﹤0.01% 2208
2017
Q1
$2.56M Buy
+50,000
New +$2.18M ﹤0.01% 1846

Other funds holding GKOS

Barclays's GKOS Position: Q1 2026 in Review

Barclays reduced its Glaukos (GKOS) stake by 85% in Q1 2026, selling an estimated $8.72M and leaving 13,613 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2531.

Barclays first reported a position in GKOS in Q4 2015 and has held it in 40 quarters since. The position peaked at $37.9M in Q1 2022. 336 funds tracked by Wall St. Rank hold GKOS as of Q1 2026.

  • Barclays held 13,613 shares of Glaukos worth $1.47M as of Q1 2026.
  • Barclays sold 77,514 Glaukos shares in Q1 2026, an estimated $8.72M.
  • Glaukos made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2531 holding.
  • Barclays first reported a position in Glaukos in Q4 2015 and has held it in 40 quarters since.
  • Barclays's Glaukos position peaked at $37.9M in Q1 2022.
  • 336 funds tracked by Wall St. Rank held Glaukos as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.